SCHEDULE 13D

Company

ONCOLYTICS BIOTECH INC

Filed

July 3, 2002

Accession Number

0001021408-02-009186

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →